Pharmaceutical

STAT+: Annexon’s trial of an eye disease drug missed by...

Annexon's trial of an eye disease drug missed by a mile. The company saw a bull'...

STAT+: Immunotherapy turned brain cancers from ‘cold’ t...

Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clini...

STAT+: Congress took on high drug prices in Medicare. N...

The Biden administration wants to help states control Medicaid prescription drug...

STAT+: Addiction treatment center founder indicted in s...

Daniel Cleggett has long been a lightning rod in the addiction recovery communit...

STAT+: Pharmalittle: Biden administration proposes year...

The administration is planning a yearly audit to verify prices drugmakers charge...

STAT+: FDA delays decision on Sarepta’s gene therapy fo...

The FDA is delaying by one month a decision on the approval of a gene therapy fo...

We’ll soon have tools to protect infants against RSV. C...

Medical professionals who care for kids are ecstatic they may soon have tools to...

Inovio’s INO-3107 receives orphan drug status from EC

INO-3107 also received orphan drug designation from the US Food and Drug Adminis...

Y-mAbs’ Danyelza injection receives marketing approval ...

Danyelza will be given three times in a week to patients and the dosage will be ...

Forge Biologics joins BGTC for new AAV gene therapies d...

BGTC creates a reusable standardised method, which reduces upfront costs and dev...

Supplies of Novo Nordisk’s Wegovy starter doses to be l...

Key opinion leaders (KOLs) interviewed by GlobalData have highlighted that despi...

FDA approves breakthrough pneumonia therapy

The FDA approved Xacduro, developed by Entasis which is now a part of Innoviva, ...

Untangling the Complexities of Cell and Gene Therapy Cl...

By Luisa Sterkel & Joana Loureiro, Tenthpin Consultants The promise and potentia...

Nona Biosciences and ModeX Therapeutics partner for ant...

ModeX will gain access to Nona Bioscience’s fully human Harbour Mice platforms.

CohBar and Morphogenesis in merger for immuno-oncology ...

The combined company will advance Morphogenesis’ personalised cancer vaccines an...

US government plans proposal to push down Medicaid drug...

The Department of Health and Human Services details new plans to survey drug cos...